BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$140M |
| 2 |
iShares US Financials ETF
IYF
|
+$119M |
| 3 |
AGN
Allergan plc
AGN
|
+$100M |
| 4 |
Charter Communications
CHTR
|
+$95.1M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$82.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.2B |
| 2 |
State Street SPDR S&P Biotech ETF
XBI
|
+$909M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$623M |
| 4 |
Apple
AAPL
|
+$389M |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$369M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.85% |
| 2 | Financials | 5.5% |
| 3 | Healthcare | 5.05% |
| 4 | Consumer Discretionary | 4.67% |
| 5 | Industrials | 3.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EMBJ
2376
Embraer S.A. ADS
EMBJ
$13.2B
| $476K | ﹤0.01% |
24,400
-15,976
| -40% | -$281K |
|
2377
Central Garden & Pet Co Class A
CENTA
$2.43B
| $475K | ﹤0.01% |
20,236
+10,877
| +116% | +$244K |
|
|
NSA
2378
DELISTED
National Storage Affiliates Trust
NSA
| $473K | ﹤0.01% |
14,071
+4,800
| +52% | +$161K |
|
2379
CALL
T-Mobile US
TMUS
$197B
| $471K | ﹤0.01% |
+60
| New | +$4.72K |
|
2380
Moelis & Co
MC
$4.91B
| $470K | ﹤0.01% |
14,724
-2,290
| -13% | -$75K |
|
2381
iShares MSCI Global Min Vol Factor ETF
ACWV
$3.38B
| $470K | ﹤0.01% |
+4,900
| New | +$466K |
|
2382
CALL
Chord Energy
CHRD
$7.35B
| $469K | ﹤0.01% |
+1,440
| New | +$4.12K |
|
2383
Planet Fitness
PLNT
$3.65B
| $469K | ﹤0.01% |
6,281
-64,860
| -91% | -$4.37M |
|
2384
Tandem Diabetes Care
TNDM
$1.61B
| $469K | ﹤0.01% |
7,868
-2,239
| -22% | -$138K |
|
2385
Installed Building Products
IBP
$6.46B
| $468K | ﹤0.01% |
6,793
+2,372
| +54% | +$160K |
|
2386
CALL
State Street Technology Select Sector SPDR ETF
XLK
$125B
| $468K | ﹤0.01% |
102
-800
| -89% | -$34.2K |
|
2387
PUT
Illinois Tool Works
ITW
$83.3B
| $467K | ﹤0.01% |
26
-46
| -64% | -$7.79K |
|
|
LOGM
2388
DELISTED
LogMein, Inc.
LOGM
| $466K | ﹤0.01% |
5,437
-2,149
| -28% | -$159K |
|
2389
Trustmark
TRMK
$2.8B
| $466K | ﹤0.01% |
13,502
-43,998
| -77% | -$1.52M |
|
|
MYOK
2390
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $465K | ﹤0.01% |
6,384
-1,599
| -20% | -$97K |
|
2391
Matthews International
MATW
$725M
| $464K | ﹤0.01% |
12,157
+6,549
| +117% | +$240K |
|
2392
Pacira BioSciences
PCRX
$924M
| $461K | ﹤0.01% |
10,182
+2,871
| +39% | +$122K |
|
2393
Mueller Water Products
MWA
$4.09B
| $457K | ﹤0.01% |
38,137
+7,919
| +26% | +$90.4K |
|
2394
Scholastic
SCHL
$784M
| $457K | ﹤0.01% |
11,876
+6,847
| +136% | +$258K |
|
|
WIRE
2395
DELISTED
Encore Wire Corp
WIRE
| $455K | ﹤0.01% |
7,935
+4,230
| +114% | +$243K |
|
2396
iShares MSCI Philippines ETF
EPHE
$146M
| $455K | ﹤0.01% |
13,269
+2,610
| +24% | +$90K |
|
|
OMP
2397
DELISTED
Oasis Midstream Partners LP Common Units Representing Limited Partner Interests
OMP
| $454K | ﹤0.01% |
27,367
+25,850
| +1,704% | +$432K |
|
2398
Viasat
VSAT
$11.4B
| $453K | ﹤0.01% |
6,187
-2,902
| -32% | -$208K |
|
2399
Iovance Biotherapeutics
IOVA
$2.95B
| $453K | ﹤0.01% |
16,349
-4,400
| -21% | -$100K |
|
|
NS
2400
DELISTED
NuStar Energy L.P.
NS
| $452K | ﹤0.01% |
17,503
-13,250
| -43% | -$369K |
|
Similar funds
BNP Paribas Financial Markets's Q4 2019 Portfolio in Review
As of Q4 2019, BNP Paribas Financial Markets held 4,613 positions worth $54.9B, down 2.5% from $56.3B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
BNP Paribas Financial Markets withdrew a net $10.1B in Q4 2019, closing 185 positions and reducing 1,420 holdings. Its most notable exit was Celgene Corp, an estimated $56.8M position sold in full.
By sector, the portfolio is most concentrated in Technology at 7.9% of assets, down from 8.4% a quarter earlier, followed by Financials and Healthcare.
Against the trend, BNP Paribas Financial Markets opened a new position in iShares US Financials ETF worth $124M.
- BNP Paribas Financial Markets's largest Q4 2019 buy was iShares US Financials ETF: 1,800,000 shares worth $124M.
- BNP Paribas Financial Markets added most to Bristol-Myers Squibb in Q4 2019, an estimated $140M increase.
- BNP Paribas Financial Markets's biggest Q4 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.2B.
- BNP Paribas Financial Markets fully exited Celgene Corp in Q4 2019, selling an estimated $56.8M.
- BNP Paribas Financial Markets's ten largest holdings make up 16% of its $54.9B portfolio in Q4 2019.
- BNP Paribas Financial Markets opened 106 new positions and closed 185 in Q4 2019.
- BNP Paribas Financial Markets's portfolio value fell 2.5% quarter-over-quarter to $54.9B.
Based on BNP Paribas Financial Markets's 13F filing for Q4 2019, filed 12 Feb 2020.